デフォルト表紙
市場調査レポート
商品コード
1186738

ゲノムシーケンシング市場:現状分析および予測(2022年~2028年)

Genome Sequencing Market: Current Analysis and Forecast (2022-2028)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 168 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
ゲノムシーケンシング市場:現状分析および予測(2022年~2028年)
出版日: 2022年12月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 168 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

ゲノムシーケンシングの市場規模は、2022年~2028年の間に約13%のCAGRで拡大すると予測されています。DNAシーケンシング技術は、第一世代から第三世代へと進歩しています。その特徴から、DNAシーケンシングシステムは人気を博しており、DNAシーケンシング市場に好影響を与えるとみられています。ゲノムシーケンシングの需要が高まっている背景には、NGSベースの診断が重視されていることと、世界的に癌の発生率が急増していることが挙げられます。

当レポートは、世界のゲノムシーケンシング市場について調査し、市場の概要とともに、製品別、技術別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場イントロダクション

第2章 ゲノムシーケンシング市場の調査手法

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 COVID-19の影響

第6章 世界のゲノムシーケンシング市場の収益、2020年~2028年

第7章 製品別の市場洞察

  • 消耗品
  • 装置
  • サービス

第8章 技術別の市場洞察

  • サンガーシーケンシング
  • 次世代シーケンシング
  • ポリメラーゼ連鎖反応
  • マイクロアレイ
  • その他

第9章 用途別の市場洞察

  • 腫瘍学
  • 生殖医療
  • 複雑な疾患の研究
  • 創薬と開発
  • 精密医療
  • 農業および動物に関する研究
  • その他

第10章 エンドユーザー別の市場洞察

  • 学術研究センター
  • 製薬会社・バイオテクノロジー企業
  • コンシューマーゲノムサービスプロバイダー
  • 政府機関
  • その他

第11章 地域別の市場洞察

  • 北米のゲノムシーケンシング市場
  • 欧州のゲノムシーケンシング市場
  • アジア太平洋のゲノムシーケンシング市場
  • そ世界のその他の地域のゲノムシーケンシング市場

第12章 ゲノムシーケンシング市場力学

  • 市場促進要因
  • 市場の課題
  • 影響分析

第13章 ゲノムシーケンシングの市場機会

第14章 ゲノムシーケンシング市場の動向と洞察

第15章 需要側と供給側の分析

第16章 バリューチェーン分析

第17章 価格分析

第18章 戦略的洞察

第19章 競合シナリオ

第20章 会社概要

  • Agilent Technologies Inc
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Qiagen NV
  • BGI Genomics Co Ltd
  • Oxford Nanopore Technologies PLC
  • Macrogen Inc
  • PerkinElmer, Inc.
  • Pacific Biosciences of California Inc
  • Bio-Rad Laboratories, Inc.

第21章 免責事項

目次
Product Code: UMME211556

The genome sequencing market is expected to register a CAGR of approx. 13% over the period of 2022-2028. The process of mapping and sequencing a person's individual DNA is known as genome sequencing. The term "genome" refers to the complete blueprint of a person's human body. A person's genes, which are a bundle of DNA, can cause a disease or increase the likelihood of disease. Genome sequencing helps to identify any significant differences in the genes, which can increase the likelihood of disease. DNA sequencing is inexpensive, has high accuracy and speed, and can produce results from small samples. DNA sequencing technologies have advanced from the first to the third generation. Because of their features, DNA sequencing systems have gained traction, which may have a positive impact on the DNA sequencing market. The growing demand for genome sequencing can be attributed to the growing emphasis on NGS-based diagnostics and surging incidences of cancer across the globe. For instance, the number of cancer cases in the US will increase 49% each year, from 1,534,500 in 2015 to 2,286,300 in 2050, with the largest percentage increase among adults aged ≥75 years, as per the predictions by CDC. Owing to the glaring statistics the increase in cancer prevalence has created a buzz among biotechnology and pharmaceutical companies for investing in the development of effective and reliable diagnostic tools which boosts the demand for genome sequencing across the globe and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the genome sequencing market is anticipated to grow on account of the rapid advancements in sequencing technology and bioinformatics. In addition, changes in lifestyle and various health-related issues drive market growth. However, some of the restraints in the market including the Lack of trained professionals and the high cost of establishing and maintaining a sequencing facility are impeding the growth of this market all over the world.

Agilent Technologies Inc; Thermo Fisher Scientific, Inc.; Illumina, Inc.; Qiagen NV; BGI Genomics Co Ltd; Oxford Nanopore Technologies PLC; Macrogen Inc; PerkinElmer, Inc.; Pacific Biosciences of California Inc; Bio-Rad Laboratories, Inc are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst product, the consumables category led the market in 2020 with the highest market share"

Based on the product, the genome sequencing market is segmented into consumables, instruments, and services. The consumables segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe. A larger share of the segment is attributed to the broad availability of reagents and kits to address all stages of library construction, including DNA fragmentation, enrichment, adapter ligation, amplification, and quality control. The majority of these tools support low-input and formalin-fixed specimens and have streamlined and simplified workflows, ready-to-use components, and components.

"Amongst technology, the next-generation sequencing category led the market in 2020 with the highest market share"

Based on the technology, the market is fragmented into sanger sequencing, next-generation sequencing, polymerase chain reaction, microarrays, and others. The next-generation sequencing segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. The rapid advancements in these technologies, combined with the decreasing cost of sequencing, have made genome sequencing faster, more affordable, and more accurate. Additionally, the use of NGS technology for routine clinical diagnostic tests is growing, especially in light of the COVID-19 infection pandemic, which benefits the segment's revenue share.

"Amongst applications, the oncology category is expected to hold considerable market share during the forecast period"

Based on the application, the market is fragmented into oncology, reproductive health, complex disease research, drug discovery and development, precision medicine, agriculture and animal research, and others. The oncology segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. The technology has enormous potential for clinical research as well as the creation of cancer diagnostics and therapeutics. Recent advancements in NGS technology have shown its potential as a high-throughput, low-cost method for identifying and characterizing clinically useful genetic variants across a wide range of genes quickly and in a single test.

"Amongst end-user, the academic & research centers category is expected to witness considerable CAGR during the forecast period"

Based on the end-user, the market is fragmented into academic & research centers, pharmaceutical and biotechnology companies, consumer genomic service providers, government institutes, and others. The academic & research centers segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period. Sanger technology and NGS are widely used in academic and institutional research projects because of their widespread acceptance. Additionally, an increase in funding and investment initiatives boosts the demand for DNA sequencing products in these organizations, leading to a higher revenue share.

"North America to witness significant growth during the forecast period"

For a better understanding of the market adoption of the genome sequencing, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the genome sequencing industry owing to the continuous technological developments by key players, high investment in R&D, availability of technologically advanced healthcare infrastructure, rising need for personalized medicine and the presence of several government initiatives in the U.S. and Canada supports research in drug development and treatment of cancer.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global genome sequencing market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Genome Sequencing Market

2 2.2. Research Methodology of the Genome Sequencing Market

  • 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE GENOME SEQUENCING MARKET

6 GLOBAL GENOME SEQUENCING MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

  • 7.1. Consumables
  • 7.2. Instruments
  • 7.3. Services

8 MARKET INSIGHTS BY TECHNOLOGY

  • 8.1. Sanger Sequencing
  • 8.2. Next-Generation Sequencing
  • 8.3. Polymerase Chain Reaction
  • 8.4. Microarrays
  • 8.5. Others

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Oncology
  • 9.2. Reproductive Health
  • 9.3. Complex Disease Research
  • 9.4. Drug Discovery and Development
  • 9.5. Precision Medicine
  • 9.6. Agriculture and Animal Research
  • 9.7. Others

10 MARKET INSIGHTS BY END-USERS

  • 10.1. Academic & Research Centers
  • 10.2. Pharmaceutical and Biotechnology Companies
  • 10.3. Consumer Genomic Service Providers
  • 10.4. Government Institutes
  • 10.5. Others

11 MARKET INSIGHTS BY REGION

  • 11.1 NORTH AMERICA GENOME SEQUENCING MARKET
    • 11.1.1 U.S.
    • 11.1.2 Canada
    • 11.1.3 Rest of North America
  • 11.2 EUROPE GENOME SEQUENCING MARKET
    • 11.2.1 Germany
    • 11.2.2 U.K.
    • 11.2.3 France
    • 11.2.4 Spain
    • 11.2.5 Italy
    • 11.2.6 Rest of Europe
  • 11.3 ASIA PACIFIC GENOME SEQUENCING MARKET
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 Australia
    • 11.3.5 Rest of Asia Pacific
  • 11.4 REST OF THE WORLD GENOME SEQUENCING MARKET

12 GENOME SEQUENCING MARKET DYNAMICS

  • 12.1 Market Drivers
  • 12.2 Market Challenges
  • 12.3 Impact Analysis

13 GENOME SEQUENCING MARKET OPPORTUNITIES

14 GENOME SEQUENCING MARKET TRENDS & INSIGHTS

15 DEMAND AND SUPPLY SIDE ANALYSIS

  • 15.1 Demand Side Analysis
  • 15.2 Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 PRICING ANALYSIS

18 STRATEGIC INSIGHTS

19 COMPETITIVE SCENARIO

  • 19.1. Competitive Landscape
    • 19.1.1 Porter's Five forces analysis

20 COMPANY PROFILED

  • 20.1. Agilent Technologies Inc
  • 20.2. Thermo Fisher Scientific, Inc.
  • 20.3. Illumina, Inc.
  • 20.4. Qiagen NV
  • 20.5. BGI Genomics Co Ltd
  • 20.6. Oxford Nanopore Technologies PLC
  • 20.7. Macrogen Inc
  • 20.8. PerkinElmer, Inc.
  • 20.9. Pacific Biosciences of California Inc
  • 20.10. Bio-Rad Laboratories, Inc.

21 DISCLAIMER